Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the developed world. The identification of the central role of vascular endothelial growth factor (VEGF) in the pathogenesis of neovascular AMD and the introduction of anti-VEGF agents as gold-standard treatment...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	British journal of ophthalmology Ročník 106; číslo 3; s. 297 - 304
Hlavní autori:	Cabral de Guimaraes, Thales Antonio, Daich Varela, Malena, Georgiou, Michalis, Michaelides, Michel
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	BMA House, Tavistock Square, London, WC1H 9JR BMJ Publishing Group Ltd 01.03.2022 BMJ Publishing Group LTD BMJ Publishing Group
Predmet:	angiogenesis Angiogenesis Inhibitors - therapeutic use Antioxidants Clinical trials degeneration Fatty acids Genes genetics Geographic Atrophy - therapy GLP-1 receptor agonists Health risk assessment Humans Lasers macula Macular degeneration Older people Oxidative stress Pathogenesis Pharmaceuticals R&D Research & development retina Review Vascular endothelial growth factor Vascular Endothelial Growth Factor A - genetics Visual Acuity Wet Macular Degeneration - drug therapy United Kingdom > UK Australia United States > US genetics retina angiogenesis degeneration macula
ISSN:	0007-1161, 1468-2079, 1468-2079
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!